BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34812417)

  • 1. Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19.
    Merrick B; Noronha M; Batra R; Douthwaite S; Nebbia G; Snell LB; Pickering S; Galao RP; Whitfield J; Jahangeer A; Gunawardena R; Godfrey T; Laifa R; Webber K; Cliff PR; Cunningham E; Neil SJD; Gettings H; Edgeworth JD; Harrison HL
    Infect Prev Pract; 2021 Dec; 3(4):100186. PubMed ID: 34812417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
    Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
    Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
    Lamb G; Heskin J; Randell P; Mughal N; Moore LS; Jones R; Davies GW; Rayment M
    J Infect; 2021 Oct; 83(4):452-457. PubMed ID: 34364950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world evaluation of rapid and laboratory-free COVID-19 triage for emergency care: external validation and pilot deployment of artificial intelligence driven screening.
    Soltan AAS; Yang J; Pattanshetty R; Novak A; Yang Y; Rohanian O; Beer S; Soltan MA; Thickett DR; Fairhead R; Zhu T; Eyre DW; Clifton DA;
    Lancet Digit Health; 2022 Apr; 4(4):e266-e278. PubMed ID: 35279399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
    Möckel M; Corman VM; Stegemann MS; Hofmann J; Stein A; Jones TC; Gastmeier P; Seybold J; Offermann R; Bachmann U; Lindner T; Bauer W; Drosten C; Rosen A; Somasundaram R
    Biomarkers; 2021 May; 26(3):213-220. PubMed ID: 33455451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Antigen Detection to Expand Testing Capacity for COVID-19: Results from a Hospital Emergency Department Testing Site.
    Menchinelli G; De Angelis G; Cacaci M; Liotti FM; Candelli M; Palucci I; Santangelo R; Sanguinetti M; Vetrugno G; Franceschi F; Posteraro B
    Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
    Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
    Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing lateral flow testing with a rapid RT-PCR method for SARS-CoV-2 detection in the United Kingdom-A retrospective diagnostic accuracy study.
    Taylor A; Calvez R; Atkins M; Fink CG
    Health Sci Rep; 2022 Sep; 5(5):e811. PubMed ID: 36177402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing.
    Peto T;
    EClinicalMedicine; 2021 Jun; 36():100924. PubMed ID: 34101770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2.
    Mistry DA; Wang JY; Moeser ME; Starkey T; Lee LYW
    BMC Infect Dis; 2021 Aug; 21(1):828. PubMed ID: 34407759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acceptability of testing contacts of confirmed COVID-19 cases using serial, self-administered lateral flow devices as an alternative to self-isolation.
    Love NK; Ready DR; Turner C; Yardley L; Rubin GJ; Hopkins S; Oliver I
    J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35947525
    [No Abstract]   [Full Text] [Related]  

  • 16. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.
    Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I
    Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2.
    Thell R; Kallab V; Weinhappel W; Mueckstein W; Heschl L; Heschl M; Korsatko S; Toedling F; Blaschke A; Herzog T; Klicpera A; Koeller C; Haugk M; Kreil A; Spiel A; Kreuzer P; Krause R; Sebesta C; Winkler S; Laky B; Szell M
    PLoS One; 2021; 16(11):e0259527. PubMed ID: 34843505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective cohort study of the effect of SARS-CoV-2 point of care rapid RT-PCR at the Emergency Department on targeted admission.
    Mortazavi SE; Inghammar M; Christiansen C; Pesola AK; Stenkilsson M; Paulsson M
    BMC Infect Dis; 2022 Jun; 22(1):536. PubMed ID: 35692041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer.
    LeBlanc JJ; McCracken GR; Goodall B; Hatchette TF; Barrett L; Ross J; Davidson RJ; Patriquin G
    Microbiol Spectr; 2022 Aug; 10(4):e0063922. PubMed ID: 35863036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic performance of two antigen-tests compared to one PCR-Test to detect SARS-CoV-2 in an emergency department and emergency service].
    Kinne V; Ehrenberg S; Baier M; Lang S; Lewejohann JC; Kipp F
    Anaesthesiologie; 2023 Nov; 72(11):791-798. PubMed ID: 37792046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.